Formerly known as ACTAVIS PHARMA COMPANY
Shortage reports
Actual shortage:
280 (9%)
Anticipated shortage:
6 (0%)
Avoided shortage:
10 (0%)
Resolved:
2981 (91%)
3277
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
484 (13%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRYPTOPHAN | 500MG | CAPSULE | Actual shortage | 2024-08-08 | 2024-08-08 | 234876 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Resolved | 2023-10-05 | 2024-03-18 | 206383 |
| TEVA-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-09-23 | 2022-05-19 | 146098 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2024-01-11 | 2024-03-18 | 215713 |
| TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-02-15 | 2024-04-11 | 219674 |
| TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-04-18 | 2024-09-19 | 225489 |
| TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2019-10-31 | 2020-03-05 | 97605 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-11-16 | 2024-03-28 | 210440 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190683 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2022-01-20 | 2022-06-16 | 153189 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2017-08-02 | 2018-03-13 | 18033 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-09-19 | 2023-10-26 | 204769 |
| TEVA-VALSARTAN | 80MG | TABLET | Actual shortage | 2025-09-04 | 2025-10-10 | 266631 |
| TEVA-VALSARTAN | 320MG | TABLET | Resolved | 2021-04-22 | 2025-04-29 | 137939 |
| TEVA-VALSARTAN | 160MG | TABLET | Actual shortage | 2025-02-06 | 2025-11-20 | 249728 |
| TEVA-VALSARTAN | 40MG | TABLET | Resolved | 2021-04-22 | 2025-04-29 | 137930 |
| TEVA-VALSARTAN | 160MG | TABLET | Resolved | 2021-04-22 | 2023-06-09 | 137936 |
| TEVA-VALSARTAN | 80MG | TABLET | Resolved | 2021-04-22 | 2025-04-29 | 137933 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-09-26 | 2025-04-25 | 94834 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Resolved | 2018-10-23 | 2025-04-25 | 65375 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RASAGILINE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258753 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258473 |
| TEVA-RISPERIDONE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258673 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258711 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258765 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258486 |
| TEVA-SUCRALFATE | 1G | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266359 |
| TEVA-TECNAL | 50MG 330MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258471 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258478 |
| TEVA-TECNAL C 1/2 | 50MG 330MG 30MG 40MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258462 |